Pluristem Manufacturing Tour - Video

Pluristem's cell manufacturing technology - PLX Bioreactor 3D system, is integrated into the world’s most advanced, automated and aseptic cell production facility, in which we can manufacture large quantities of cells of the highest quality in a cost-effective, reproducible and consistent manner. This capability is necessary for any cell therapy to become a true commercial product. Pluristem’s state-of-the-art manufacturing site is located in the MATAM industrial park in Haifa, Israel, and is equipped with 500m2 clean rooms with the capacity to manufacture cells to support clinical trials and initial commercial needs upon achieving marketing approval. Pluristem Therapeutics develops and manufactures its products in full compliance with international quality standards. Our Chemistry, Manufacturing, and Controls (CMC) and our manufacturing facility for PLX-PAD cells have been approved by the FDA and the German, EU, South Korean, Japanese & Israeli regulatory agencies for 3D culturing to supply cells for clinical trials and marketing. In this video- a short virtual tour at Pluristem's manufacturing facility.